Recruiting

Radiation Therapy

Sponsor:

University Health Network, Toronto

Code:

NCT07945470

Conditions

Indolent B-Cell Non-Hodgkin Lymphoma

Marginal Zone Lymphoma

Follicular Lymphoma

Small Lymphocytic Lymphoma

Mantle Cell Lymphoma (MCL)

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Simulation-Free Single-Fraction Radiation Therapy (4 Gy × 1)

Study Details

Brief summary:

This pilot study will evaluate whether people with indolent B-cell lymphoma can receive radiation therapy without a separate computed tomography (CT) simulation appointment. Participants will receive one low-dose radiation treatment of 4 gray (Gy). Treatment planning will use a recent diagnostic CT scan, and cone-beam computed tomography (CBCT) imaging on the treatment day will be used to confirm participant positioning and adjust the treatment plan if needed.

The study includes participants with orbital or ocular adnexal lymphoma and participants with lymphoma at other body sites. The investigators will assess whether simulation-free treatment can be completed successfully, treatment duration, the number of hospital visits required, treatment side effects, patient-reported symptoms, control of the treated lymphoma site, and the need for additional treatment. Participants will be followed for up to 12 months.

Conditions

Indolent B-Cell Non-Hodgkin Lymphoma

Marginal Zone Lymphoma

Follicular Lymphoma

Small Lymphocytic Lymphoma

Mantle Cell Lymphoma (MCL)

Study ID

NCT07945470

Start date

Oct 9, 2026

Status verified date

Nov, 2026

Completion date

Dec 31, 2028

Anticipated

Primary completion date

Dec 31, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Histologically confirmed indolent B-cell lymphoma, including marginal zone/mucosa-associated lymphoid tissue (MALT) lymphoma, follicular lymphoma grades 1-2, small lymphocytic lymphoma, or mantle cell lymphoma.
  • Disease requiring focal radiation therapy with 4 Gy delivered in one fraction for local control or symptom relief.
  • Lesion anatomy suitable for single-fraction radiation therapy and simulation-free, CBCT-guided treatment delivery, as determined by the treating radiation oncologist.
  • Available diagnostic CT imaging suitable for contouring and dose calculation that encompasses the full intended target and relevant organs at risk:
  • Obtained within 2 months before treatment for orbital or ocular adnexal disease.
  • Obtained within 6 weeks before treatment for non-orbital disease.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-3, with the ability to tolerate treatment positioning and delivery.
  • Localized or advanced-stage disease is permitted, provided the target lesion is appropriate for focal treatment.

Exclusion Criteria:

  • Diagnostic imaging that does not meet the minimum quality requirements for treatment planning or falls outside the required time window.
  • Disease anatomy unsuitable for simulation-free delivery, such as inability to maintain stable positioning, excessive motion, or inadequate CBCT visualization.
  • Prior radiation therapy to the same site if re-irradiation using the study workflow is considered clinically inappropriate.
  • Bulky disease greater than 6 centimeters for which single-fraction 4 Gy radiation therapy is unlikely to provide adequate local control, as determined by the treating physician.
  • Requirement for urgent systemic therapy because of widespread or symptomatic disease.

Study Design

Enrollment

60 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Simulation-Free Single-Fraction Radiation Therapy

Participants will receive simulation-free, cone-beam computed tomography (CBCT)-guided adaptive radiation therapy delivered as a single 4 gray (Gy) fraction. Treatment planning will use a recent diagnostic computed tomography (CT) scan instead of a separate planning CT simulation. CBCT imaging will be obtained on the treatment day to confirm positioning and anatomy and to adapt the treatment plan when needed. Participants for whom the simulation-free workflow is not feasible will proceed to standard CT simulation-based treatment.

Interventions

Simulation-Free Single-Fraction Radiation Therapy (4 Gy × 1)

Participants will receive a single 4 gray (Gy) fraction of radiation therapy using a simulation-free workflow. A recent diagnostic computed tomography (CT) scan suitable for contouring and dose calculation will be used for initial treatment planning instead of a separate planning CT simulation. On the treatment day, cone-beam computed tomography (CBCT) imaging will be obtained to confirm positioning and anatomy. The treatment plan may be adapted on the treatment couch and will undergo physician and physics review before radiation is delivered. If a clinically acceptable simulation-free plan cannot be produced, the participant will proceed to the standard CT simulation-based workflow.

Primary outcome measure

  • Successful Completion of Simulation-Free Radiation Therapy [ Time Frame: Periprocedural (single radiation treatment session) ]

Central Contacts and Locations

Central contacts

Locations

Princess Margaret Cancer Centre, University Health Network

Recruiting

Toronto, Ontario, Canada, M5G 1X6

Contacts

More Information

Sponsor

University Health Network, Toronto

Last update posted

Nov 18, 2026

Last verified

Nov, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.